Cell & Gene Therapy Market to Reach Revenue of USD 36.92 Billion by 2027 – Arizton

The cell & gene therapy market is projected to grow at a CAGR of over 39% during the period 2022−2027.

The increasing number of product approvals and a growing number of clinical trials for cell/gene therapy products gives a new shape to the cell & gene therapy market. PRIME Designation and marketing authorization for products offering new opportunity for financing and revenue generation for manufacturers. The advancements in cell and gene therapy as well as the launch of innovative technologies have paved the way for a new era in biological therapeutics. Manufacturers should focus on the emerging economies for expansion of their business due to the potential market and customer base. Arizton's research reports offer in-depth and insightful information to grow your business profitability!

Key Highlights

• The rising application of cell and gene therapy solution for diseases care driving the market growth.
• The increasing financial and rising investment in cell and gene therapy development will offer market growth opportunity in upcoming years.
• The continuously increasing CGT product approval application and prime designation support creating a new space for market developments.
• The prevalence of rare diseases and effectiveness of gene therapy products creating lucrative opportunities for the vendors to boost their presence in the cell and gene therapy market.
• Gene therapy products accounted higher market share over the cell therapy products and increasing with healthy CAGR.
• Cell and Gene Therapy products are majorly used to treat cancer condition and it accounted higher market size by application segment.
• By end-user segment, hospitals accounted higher market share in cell and gene therapy market.

Cell & Gene Therapy Market - Segmentation

The increasing number of mergers & acquisitions of smaller companies by large cell & gene therapy manufacturers, the continuous focus on the expansion of manufacturing units across the globe, as well as setting up of new facilities by key vendors are propelling the market growth. The increasing application of gene therapies in disease diagnosis and rapid increasing of new drugs applications will boost the market development in the upcoming years. However, billions of funding and financing are giving new space for cell therapy innovations. Most of the new startups and smaller pharmaceutical companies are looking ahead with cell therapy innovations, which is propelling the market growth for cell therapies.

Market segmentation by Therapy Type
• Gene Therapy
• Cell Therapy
Market segmentation by Application
• Oncology
• Genetic Disorders
• Dermatology Disorders
• Musculoskeletal Disorders
• Others
Market segmentation by End-Users
• Hospitals
• Cancer Care Centers
• Wound Care Centers
• Others
Market segmentation by Geography
• North America
• US
• Canada
• Europe
• Germany
• France
• UK
• Spain
• Italy
• APAC
• Japan
• China
• South Korea
• Australia
• India
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• South Africa
• Israel
For more info: https://www.arizton.com/market-reports/cell-and-gene-therapy-market
Cell & Gene Therapy Market – Table of Content

1 Research Methodology
2 Research Objectives
3 Research Process

4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of The Study
4.3.1 Market Segmentation by Technology
4.3.2 Market Segmentation by Product
4.3.3 Market Segmentation by Application
4.3.4 Market Segmentation by End-User
4.3.5 Market Segmentation by Geography

5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation

6 Market at a Glance
7 Introduction
7.1 Overview
7.1.1 Evolution of PCR
7.2 COVID-19 Pandemic
7.2.1 Overview

8 Market Opportunities & Trends
8.1 Surge in The Demand for PCR Tests Due to Covid-19
8.2 Increase in The Demand for Point-Of-Care (POC) PCR Diagnostics
8.3 Paradigm Shift Towards the Usage Of dPCR

9 Market Growth Enablers
9.1 Increase in the Prevalence of Infectious Diseases and Genetic Disorders
9.2 Technological Advancements in PCR
9.3 Expanding Application of PCR Post Human Genome Project

10 Market Restraints
10.1 Technical Limitations of PCR
10.2 High Cost of PCR
10.3 Low Penetration of PCR Instruments in LMICs

11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry

12 Technology
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Real-Time PCR
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 Digital PCR
12.4.1 Market Overview
12.4.2 Market Size & Forecast

13 Product
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Consumables
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.4 Systems/Analyzers & Software
13.4.1 Market Overview
13.4.2 Market Size & Forecast

14 Application
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Clinical Applications
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.4 Research Applications
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.5 Forensic Applications
14.5.1 Market Overview
14.5.2 Market Size & Forecast

15 End-User
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Diagnostic Laboratories
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.4 Hospitals
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.5 Research Laboratories
15.5.1 Market Overview
15.5.2 Market Size & Forecast
15.6 Pharma & Biotech Companies
15.6.1 Market Overview
15.6.2 Market Size & Forecast
15.7 Forensic Laboratories
15.7.1 Market Overview
15.7.2 Market Size & Forecast
15.8 Others
15.8.1 Market Overview
15.8.2 Market Size & Forecast

Prominent Vendors
• Agilent Technologies Inc.
• Quidel
• QIAGEN
• Takara Bio
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Danaher
• F.Hoffmann-La Roche
Other Prominent Vendors
• Abbott
• BD
• bioMérieux
• Convergent Technologies
• FLUIDIGM
• Promega
• Analytik Jena Group
• Meridian Bioscience
• Eppendorf
• Enzo Life Sciences
• BIONEER
• ELITechGroup
• Quantabio
• Sacace Biotechnologies
• Bio Molecular Systems
• Biomeme
• JN Medsys
• Anitoa Systems
• ACTGene
• Mylab Discovery Solutions
• Amplyus
• Blue-Ray Biotech
• PentaBase
• Hologic
• GenMark Diagnostics
• Luminex
• Mobidiag
• PathoFinder
• Acupath Laboratories
• ALTRU DIAGNOSTICS
• Altona Diagnostics
• BGI
• BioCore
• Fosun Pharma
• General Biologicals Corporation (GBC)
• GeneStore
• Gnomegen
• KogeneBiotech

About Arizton  
   
Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.   
  
We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.   
  
Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.   
  

Mail: enquiry@arizton.com   
Call: +1-312-235-2040   
          +1 302 469 0707   
   

This release was published on openPR.